Haemonetics Price to Book Ratio 2010-2025 | HAE
Historical price to book ratio values for Haemonetics (HAE) over the last 10 years. The current price to book ratio for Haemonetics as of July 08, 2025 is 4.65.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Haemonetics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-08 | 75.97 | 4.46 | |
| 2025-03-31 | 63.55 | $17.02 | 3.73 |
| 2024-12-31 | 78.08 | $18.05 | 4.33 |
| 2024-09-30 | 80.38 | $17.44 | 4.61 |
| 2024-06-30 | 82.73 | $17.70 | 4.67 |
| 2024-03-31 | 85.35 | $18.90 | 4.52 |
| 2023-12-31 | 85.51 | $18.57 | 4.60 |
| 2023-09-30 | 89.58 | $17.61 | 5.09 |
| 2023-06-30 | 85.14 | $17.05 | 4.99 |
| 2023-03-31 | 82.75 | $16.21 | 5.10 |
| 2022-12-31 | 78.65 | $15.38 | 5.11 |
| 2022-09-30 | 74.03 | $14.41 | 5.14 |
| 2022-06-30 | 65.18 | $15.01 | 4.34 |
| 2022-03-31 | 63.22 | $14.66 | 4.31 |
| 2021-12-31 | 53.04 | $14.30 | 3.71 |
| 2021-09-30 | 70.59 | $13.68 | 5.16 |
| 2021-06-30 | 66.64 | $13.27 | 5.02 |
| 2021-03-31 | 111.01 | $14.38 | 7.72 |
| 2020-12-31 | 118.75 | $14.15 | 8.39 |
| 2020-09-30 | 87.25 | $13.17 | 6.62 |
| 2020-06-30 | 89.56 | $12.01 | 7.46 |
| 2020-03-31 | 99.66 | $11.67 | 8.54 |
| 2019-12-31 | 114.90 | $11.40 | 10.08 |
| 2019-09-30 | 126.14 | $11.53 | 10.94 |
| 2019-06-30 | 120.34 | $11.64 | 10.34 |
| 2019-03-31 | 87.48 | $13.09 | 6.68 |
| 2018-12-31 | 100.05 | $12.61 | 7.93 |
| 2018-09-30 | 114.58 | $13.59 | 8.43 |
| 2018-06-30 | 89.68 | $13.05 | 6.87 |
| 2018-03-31 | 73.16 | $14.38 | 5.09 |
| 2017-12-31 | 58.08 | $15.41 | 3.77 |
| 2017-09-30 | 44.87 | $15.21 | 2.95 |
| 2017-06-30 | 39.49 | $14.71 | 2.68 |
| 2017-03-31 | 40.57 | $14.15 | 2.87 |
| 2016-12-31 | 40.20 | $14.87 | 2.70 |
| 2016-09-30 | 36.21 | $14.54 | 2.49 |
| 2016-06-30 | 28.99 | $14.01 | 2.07 |
| 2016-03-31 | 34.98 | $14.17 | 2.47 |
| 2015-12-31 | 32.24 | $14.17 | 2.28 |
| 2015-09-30 | 32.32 | $15.35 | 2.11 |
| 2015-06-30 | 41.36 | $15.56 | 2.66 |
| 2015-03-31 | 44.92 | $15.99 | 2.81 |
| 2014-12-31 | 37.42 | $16.19 | 2.31 |
| 2014-09-30 | 34.92 | $15.99 | 2.18 |
| 2014-06-30 | 35.28 | $15.85 | 2.23 |
| 2014-03-31 | 32.59 | $16.10 | 2.02 |
| 2013-12-31 | 42.13 | $15.90 | 2.65 |
| 2013-09-30 | 39.88 | $15.46 | 2.58 |
| 2013-06-30 | 41.35 | $15.07 | 2.74 |
| 2013-03-31 | 41.66 | $15.07 | 2.76 |
| 2012-12-31 | 40.84 | $15.09 | 2.71 |
| 2012-09-30 | 40.10 | $14.97 | 2.68 |
| 2012-06-30 | 37.06 | $14.77 | 2.51 |
| 2012-03-31 | 34.84 | $14.48 | 2.41 |
| 2011-12-31 | 30.61 | $14.03 | 2.18 |
| 2011-09-30 | 29.24 | $13.58 | 2.15 |
| 2011-06-30 | 32.19 | $13.82 | 2.33 |
| 2011-03-31 | 32.77 | $13.37 | 2.45 |
| 2010-12-31 | 31.59 | $12.76 | 2.48 |
| 2010-09-30 | 29.27 | $12.01 | 2.44 |
| 2010-06-30 | 26.76 | $11.45 | 2.34 |
| 2010-03-31 | 28.58 | $11.66 | 2.45 |
| 2009-12-31 | 27.58 | $11.41 | 2.42 |
| 2009-09-30 | 28.06 | $11.31 | 2.48 |
| 2009-06-30 | 28.50 | $10.98 | 2.60 |
| 2009-03-31 | 27.54 | $10.54 | 2.61 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.650B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.025B | 27.90 |
| Boston Scientific (BSX) | United States | $151.510B | 37.93 |
| Stryker (SYK) | United States | $148.668B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $135.285B | 0.00 |
| Medtronic (MDT) | Ireland | $113.608B | 16.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.270B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.623B | 28.26 |
| GE HealthCare Technologies (GEHC) | United States | $34.433B | 16.35 |
| Agilent Technologies (A) | United States | $34.375B | 22.41 |
| Terumo (TRUMY) | Japan | $24.785B | 32.19 |
| Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
| Insulet (PODD) | United States | $20.867B | 81.91 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.493B | 11.88 |
| Baxter (BAX) | United States | $15.734B | 11.75 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.038B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.823B | 23.74 |
| Lantheus Holdings (LNTH) | United States | $5.702B | 14.38 |
| Prestige Consumer Healthcare (PBH) | United States | $3.885B | 17.35 |
| Perrigo (PRGO) | Ireland | $3.731B | 9.46 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.415B | 28.38 |
| ICU Medical (ICUI) | United States | $3.262B | 24.05 |
| QuidelOrtho (QDEL) | United States | $2.084B | 14.34 |
| LeMaitre Vascular (LMAT) | United States | $1.896B | 42.38 |
| AtriCure (ATRC) | United States | $1.566B | 0.00 |
| Acuren (TIC) | United States | $1.379B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.286B | 13.06 |
| Phibro Animal Health (PAHC) | United States | $1.221B | 15.61 |
| Green Thumb Industries (GTBIF) | United States | $1.211B | 27.24 |
| Neogen (NEOG) | United States | $1.137B | 14.56 |
| BioLife Solutions (BLFS) | United States | $1.071B | 0.00 |
| InMode (INMD) | Israel | $0.971B | 9.78 |
| Kestra Medical Technologies (KMTS) | United States | $0.810B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Owens & Minor (OMI) | United States | $0.695B | 5.76 |
| Curaleaf Holdings (CURLF) | Canada | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Evolus (EOLS) | United States | $0.597B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.594B | 0.00 |
| Valneva SE (VALN) | France | $0.497B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| SNDL (SNDL) | Canada | $0.363B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Quanterix (QTRX) | United States | $0.327B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.322B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.299B | 0.00 |
| Cerus (CERS) | United States | $0.279B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.40 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.268B | 12.19 |
| Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 76.00 |
| Brainsway (BWAY) | Israel | $0.243B | 64.35 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.222B | 6.25 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.23 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.127B | 15.61 |
| TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.47 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Jin Medical (ZJYL) | China | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.57 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.84 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |